Axogen Inc vs iShares Gold Trust — how do they compare? Axogen Inc trades at $38.37 (market cap $2.06B), while iShares Gold Trust trades at $76.17. The key difference: Axogen Inc is trading nearer its 52-week high, iShares Gold Trust nearer its low. Which is the better fit depends on your goals.
| AXGN | IAU | |
|---|---|---|
Market Cap | $2.06B | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $46.19 | $101.57 |
52-Week Low | $11.28 | $61.62 |
Enterprise Value | $1.98B | — |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
IAU, the iShares Gold Trust ETF, is trading at $75.25, down 2.6% with a bearish technical outlook. The ETF faces pressure from rising Treasury yields and Federal Reserve policy uncertainty, though recent weaker CPI data provided temporary support. Gold remains a key asset amid geopolitical tensions and central bank accumulation, with the fund offering low-cost exposure to physical gold.
The outlook for IAU is mixed, balancing strong long-term fundamentals against near-term headwinds. Gold's role as a hedge and central bank demand provide support, but Fed policy and dollar strength pose risks. The ETF's structure offers efficient gold access, but price volatility requires careful position sizing.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →IAU is a physically backed ETF that seeks to reflect the performance of the price of gold. It provides a convenient and liquid way for investors to include gold in their portfolios as a potential hedge.
Read more on IAU →